Conference Correspondent  - ASCO 2021 Wrap-Up - Breast Cancer

Cancer therapy is experiencing a shift in drug delivery from systemic chemotherapy to more targeted oral medications. Health systems are developing multidisciplinary teams that collaborate with an oncology clinical pharmacist to provide patient education as well as dispense and perform an extensive review of the use of oral antineoplastic treatments from initiation throughout the duration of treatment. The VA CARES program is one such initiative that provides medication management services to veterans via a telemedicine clinic. The primary goals for the VA CARES program include safety (number and type of pharmacist interventions), cost-savings or cost avoidance, and patient satisfaction.

Veterans are automatically enrolled in the program when they are prescribed oral antineoplastic treatments that are to be dispensed by Veterans Affairs (VA). The program enrolled 108 veterans with 27 cancer types and 35 different oral treatments from 3 VA medical facilities from January 2020 to January 2021. Improved safety, effectiveness, and/or cost benefit resulted from 501 telemedicine visits and 129 interventions. Oncology clinical pharmacist interventions most commonly included detection and/or prevention of drug–drug interactions (n = 57) and adverse events (n = 29), drug not indicated (n = 15), alternative therapy suggested (n = 15), and limited-quantity dispensed (n = 7). Program patient satisfaction surveys indicate veterans were highly satisfied with the services received.

Telemedicine in an oncology setting and pharmacist-led management of medication is achievable and provides clinical and economic benefits with high patient satisfaction. The VA CARES program can serve as a model for remotely delivering highly coordinated care to patients with cancer receiving oral antineoplastic treatments.

Source: Healy R, Passey D, Pinnell D, et al. Veterans on anticancer medications in rural and community environment support (VA CARES) program: a pharmacist-led telemedicine medication management program for veterans receiving oral antineoplastic therapies through the MISSION Act. American Society of Clinical Oncology Virtual Meeting; June 4-8, 2021. Abstract 1545.

Related Items
Necessity for Increased Screening for Genetic Testing Eligibility Among Long-Term Breast Cancer Survivors
Conference Correspondent  published on June 14, 2021 in ASCO 2021 Wrap-Up - Breast Cancer
Weight Gain in Breast Cancer Patients During Adjuvant Endocrine Therapy Linked to Menopausal Status
Conference Correspondent  published on June 14, 2021 in ASCO 2021 Wrap-Up - Breast Cancer
Real-Life Study of Alpelisib plus Fulvestrant Therapy After Treatment with CDK4/6 Inhibitor in French Breast Cancer Patients
Conference Correspondent  published on June 14, 2021 in ASCO 2021 Wrap-Up - Breast Cancer
Implications for Use of Subjective Social Status as a Risk Factor for Metabolic Syndrome in Black Women with New Breast Cancer Diagnosis
Conference Correspondent  published on June 14, 2021 in ASCO 2021 Wrap-Up - Breast Cancer
Last modified: July 22, 2021